Eculizumab for bevacizumab induced thrombotic microangiopathy: A case report

• Main Authors: Mihriban İnözü (Author), Sare Gülfem Özlü (Author), Derya Özyörük (Author), Saba Kiremitçi (Author), Selma Çakmakçı (Author), Begüm Avcı (Author), Sonay İncesoy Özdemir (Author), Umut Selda Bayrakçı (Author)
• Format: Book
• Published: Elsevier, 2022-12-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Bevacizumab is a monoclonal human antibody that is effective in the treatment of cancers in both adults and children due to inhibition of vascular endothelial growth factor. Throbotic microangiopathy (TMA) is well-known complication of bevacizumab. Herein, we report a case of desmoplastic small roun...